Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor

Kosorok, 1996, The incidence of cystic fibrosis, Stat Med, 15, 449, 10.1002/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X Faro, 2012, Pulmonary Disease in Cystic Fibrosis Ramsey, 2011, A CFTR potentiator in patients with cystic fibrosis and the G551D mutation, N Engl J Med, 365, 1663, 10.1056/NEJMoa1105185 Rowe, 2014, Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis, Am J Respir Crit Care Med, 190, 175, 10.1164/rccm.201404-0703OC Heltshe, 2015, Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor, Clin Infect Dis, 60, 703, 10.1093/cid/ciu944 Boyle, 2014, A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial, Lancet Respir Med, 2, 527, 10.1016/S2213-2600(14)70132-8 Modi, 2006, A multi-method assessment of treatment adherence for children with cystic fibrosis, J Cyst Fibros, 5, 177, 10.1016/j.jcf.2006.03.002 Quittner, 2000, Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information, J Clin Psychol Med Settings, 7, 41, 10.1023/A:1009545319673 Rappoff, 2010 Briesacher, 2011, Adherence with tobramycin inhaled solution and health care utilization, BMC Pulm Med, 11, 5, 10.1186/1471-2466-11-5 Nasr, 2013, Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis, J Med Econ, 16, 801, 10.3111/13696998.2013.787427 Wertz, 2011, Economic impact of tobramycin in patients with cystic fibrosis in a managed care population, J Med Econ, 14, 759, 10.3111/13696998.2011.621004 Rapoff, 2005, Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis, Arthritis Rheum, 53, 905, 10.1002/art.21603 Maikranz, 2007, The relationship of hope and illness-related uncertainty to emotional adjustment and adherence among pediatric renal and liver transplant recipients, J Pediatr Psychol, 32, 571, 10.1093/jpepsy/jsl046 Modi, 2006, A multi-method assessment of treatment adherence for children with cystic fibrosis, J Cyst Fibros, 5, 177, 10.1016/j.jcf.2006.03.002 Quittner, 2008, Evidence-based assessment of adherence to medical treatments in pediatric psychology, J Pediatr Psychol, 33, 916, 10.1093/jpepsy/jsm064 Quittner, 2000, Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family-based interventions Ball, 2013, Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time, J Cyst Fibros, 12, 440, 10.1016/j.jcf.2012.12.012 Accurso, 2010, Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation, N Engl J Med, 363, 1991, 10.1056/NEJMoa0909825